The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Designing a broad-spectrum integrative approach for cancer prevention and treatment
Open accessAbstract
Targeted therapies and the consequent adoption of "personalized" oncology have achieved notable successes in some cancers; however, significant problems remain with this approach. Many targeted therapies are highly toxic, costs are extremely high, and most patients experience relapse after a few disease-free months. Relapses arise from genetic heterogeneity in tumors, which harbor therapy-resistant immortalized cells that have adopted alternate and compensatory pathways (i.e., pathways that are not reliant upon the same mechanisms as those which have been targeted). To address these limitations, an international task force of 180 scientists was assembled to explore the concept of a low-toxicity "broad-spectrum" therapeutic approach that could simultaneously target many key pathways and mechanisms. Using cancer hallmark phenotypes and the tumor microenvironment to account for the various aspects of relevant cancer biology, interdisciplinary teams reviewed each hallmark area and nominated a wide range of high-priority targets (74 in total) that could be modified to improve patient outcomes. For these targets, corresponding low-toxicity therapeutic approaches were then suggested, many of which were phytochemicals. Proposed actions on each target and all of the approaches were further reviewed for known effects on other hallmark areas and the tumor microenvironment. Potential contrary or procarcinogenic effects were found for 3.9% of the relationships between targets and hallmarks, and mixed evidence of complementary and contrary relationships was found for 7.1%. Approximately 67% of the relationships revealed potentially complementary effects, and the remainder had no known relationship. Among the approaches, 1.1% had contrary, 2.8% had mixed and 62.1% had complementary relationships. These results suggest that a broad-spectrum approach should be feasible from a safety standpoint. This novel approach has potential to be relatively inexpensive, it should help us address stages and types of cancer that lack conventional treatment, and it may reduce relapse risks. A proposed agenda for future research is offered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 2×
“survival strategies distinguishing CSCs from normal tissue stem cells involve lack of cellular differentiation and alterations in cell metabolism, such as higher antioxidant levels [83,84].”
BackgroundDietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 3×
“At more advanced stages, progressive genomic instability in the tumor leads to mutations in pathways regulating the production of multiple angiogenic factors [131], and stroma cells also become important sources of sustained angiogenic factor production [29].”
BackgroundMotzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,181
Nutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×
“Free radicals and aldehydes, produced during chronic inflammation, can also induce deleterious gene mutation and post-translational modifications of key cancer-related proteins [125].”
BackgroundSelf-citationMutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Traditional Chinese medicine network pharmacology: theory, methodology and application
LI, S., & ZHANG, B. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60037-0 · Cited by 1,329
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“specifically in cancer cells by blocking cyclin-dependent kinase mediated inhibition of RB-family proteins [111], or by exploiting”
BackgroundAACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Coussens, L. M., Zitvogel, L., & Palucka, A. K. (2013) · Science · doi:10.1126/science.1232227 · Cited by 1,079
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,049
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 2×
“[108] Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC.”
BackgroundMechanisms of adverse effects of anti-VEGF therapy for cancer
Kamba, T., & McDonald, D. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603813 · Cited by 990
Traditional Chinese medicine network pharmacology: theory, methodology and application
LI, S., & ZHANG, B. (2014) · Chinese Journal of Natural Medicines · doi:10.3724/sp.j.1009.2013.00110 · Cited by 967
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Easwaran, H., Tsai, H.-C., & Baylin, S. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.015 · Cited by 915
Stein, G. H., Drullinger, L. F., Soulard, A., & Dulić, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2109 · Cited by 868
Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Chlebowski, R. T., Blackburn, G. L., Thomson, C. A., Nixon, D. W., Shapiro, A., Hoy, M. K., Goodman, M. T., Giuliano, A. E., Karanja, N., McAndrew, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj494 · Cited by 825
Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate
Khan, N., Afaq, F., Saleem, M., Ahmad, N., & Mukhtar, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3636 · Cited by 820
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Genetic determinants of cancer metastasis
Nguyen, D. X., & Massagué, J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2101 · Cited by 801
Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Fong, D. Y. T., Ho, J. W. C., Hui, B. P. H., Lee, A. M., Macfarlane, D. J., Leung, S. S. K., Cerin, E., Chan, W. Y. Y., Leung, I. P. F., Lam, S. H. S., et al. (2012) · BMJ · doi:10.1136/bmj.e70 · Cited by 782
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 775
Meyerhardt, J. A., Heseltine, D., Niedzwiecki, D., Hollis, D., Saltz, L. B., Mayer, R. J., Thomas, J., Nelson, H., Whittom, R., Hantel, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0863 · Cited by 759
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728 · cited 2×
“In the case of telomere and telomerase based strategies, replicative senescence may occur more readily in rapidly dividing cancer cells bearing short telomeres than in slowly dividing stem cells with comparatively longer telomeres, but telomere lengths in cancer cells may still be long enough to permit sufficient popu…”
BackgroundMechanisms and insights into drug resistance in cancer
Zahreddine, H., & Borden, K. L. B. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00028 · Cited by 660
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
Gagnier, J. J., Boon, H., Rochon, P., Moher, D., Barnes, J., Bombardier, C., & for the CONSORT Group* (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00013 · Cited by 608
Li, X., Yang, G., Li, X., Zhang, Y., Yang, J., Chang, J., Sun, X., Zhou, X., Guo, Y., Xu, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060338 · Cited by 603
Leukemia, E. I. C. M. (2013) · Blood · doi:10.1182/blood-2013-03-490003 · Cited by 592
Dietary factors affecting polyphenol bioavailability
Bohn, T. (2014) · Nutrition Reviews · doi:10.1111/nure.12114 · Cited by 575
Perspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Self-citationAssociation between dietary inflammatory index and inflammatory markers in the HELENA study
Shivappa, N., Hebert, J. R., Marcos, A., Diaz, L., Gomez, S., Nova, E., Michels, N., Arouca, A., González‐Gil, E., Frederic, G., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600707 · Cited by 537
Weber, J. S., Kudchadkar, R. R., Yu, B., Gallenstein, D., Horak, C. E., Inzunza, H. D., Zhao, X., Martinez, A. J., Wang, W., Gibney, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4802 · Cited by 535
Self-citationShay, J. W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.677 · Cited by 509
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 478
Goel, A., & Aggarwal, B. B. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.509835 · Cited by 464
Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study
Shivappa, N., Hébert, J. R., Rietzschel, E. R., De Buyzere, M. L., Langlois, M., Debruyne, E., Marcos, A., & Huybrechts, I. (2015) · British Journal of Nutrition · doi:10.1017/s000711451400395x · Cited by 453
Multitargeted therapy of cancer by silymarin
Ramasamy, K., & Agarwal, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.053 · Cited by 442
Meyerhardt, J. A., Niedzwiecki, D., Hollis, D., Saltz, L. B., Hu, F. B., Mayer, R. J., Nelson, H., Whittom, R., Hantel, A., Thomas, J., et al. (2007) · JAMA · doi:10.1001/jama.298.7.754 · Cited by 437
Antioxidants and cancer, part 3: quercetin.
Lamson, D. W., & Brignall, M. S. (2000) · PubMed · Cited by 414
Drug resistance in cancer: Principles of emergence and prevention
Komarova, N. L., & Wodarz, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501870102 · Cited by 414
Angiogenesis Ischemic and Neoplastic Disorders
Semenza, G. L. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152418 · Cited by 386
Karlsen, A., Retterstøl, L., Laake, P., Paur, I., Kjølsrud-Bøhn, S., Sandvik, L., & Blomhoff, R. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.8.1951 · Cited by 384
Nandakumar, V., Vaid, M., & Katiyar, S. K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq285 · Cited by 368
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
Oxidants, antioxidants and the current incurability of metastatic cancers
Watson, J. (2013) · Open Biology · doi:10.1098/rsob.120144 · Cited by 354
Kiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., & Glaser, R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.229 · Cited by 340
Bacteria in cancer therapy: a novel experimental strategy
Patyar, S., Joshi, R., Byrav, D. P., Prakash, A., Medhi, B., & Das, B. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-21 · Cited by 340
Curcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
Block, K. I., Koch, A. C., Mead, M. N., Tothy, P. K., Newman, R. A., & Gyllenhaal, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23754 · Cited by 328
Self-citationCancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
Self-citationImmune microenvironments in solid tumors: new targets for therapy
Shiao, S. L., Ganesan, A. P., Rugo, H. S., & Coussens, L. M. (2011) · Genes & Development · doi:10.1101/gad.169029.111 · Cited by 322
A critical role for telomeres in suppressing and facilitating carcinogenesis
Artandi, S. E., & DePinho, R. A. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00047-7 · Cited by 318
New aspects of the Warburg effect in cancer cell biology
Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 307
Lee, C., & Longo, V. D. (2011) · Oncogene · doi:10.1038/onc.2011.91 · Cited by 303
Self-citationBarton, D. L., Liu, H., Dakhil, S. R., Linquist, B., Sloan, J. A., Nichols, C. R., McGinn, T. W., Stella, P. J., Seeger, G. R., Sood, A., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt181 · Cited by 298
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
One mouse, one patient paradigm: New avatars of personalized cancer therapy
Malaney, P., Nicosia, S. V., & Davé, V. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.010 · Cited by 289
Weber, J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-7-864 · Cited by 286
Hanahan, D. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62226-6 · Cited by 271
The Inflammation and Liver Cancer
Bishayee, A. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_16 · Cited by 255
Self-citationGordon, I., Paoloni, M., Mazcko, C., & Khanna, C. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000161 · Cited by 241
Systemic cancer therapy: achievements and challenges that lie ahead
Palumbo, M. O., Kavan, P., Miller, W. H., Panasci, L., Assouline, S., Johnson, N., Cohen, V., Patenaude, F., Pollak, M., Jagoe, R. T., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00057 · Cited by 241
Montonen, J., Boeing, H., Fritsche, A., Schleicher, E., Joost, H.-G., Schulze, M. B., Steffen, A., & Pischon, T. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0340-6 · Cited by 234
Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S. B., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205132109 · Cited by 234
Self-citationLv, Q.-W., Zhang, W., Shi, Q., Zheng, W.-J., Li, X., Chen, H., Wu, Q.-J., Jiang, W.-L., Li, H.-B., Gong, L., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204807 · Cited by 233
Self-citationSomatic inactivation of genes on chromosome 13 is a common event in retinoblastoma
Godbout, R., Dryja, T. P., Squire, J., Gallie, B. L., & Phillips, R. A. (1983) · Nature · doi:10.1038/304451a0 · Cited by 232
Block, K. I., Koch, A. C., Mead, M. N., Tothy, P. K., Newman, R. A., & Gyllenhaal, C. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.01.005 · Cited by 231
Self-citationUrpi-Sarda, M., Casas, R., Chiva-Blanch, G., Romero-Mamani, E. S., Valderas-Martínez, P., Arranz, S., Andres-Lacueva, C., Llorach, R., Medina-Remón, A., Lamuela-Raventos, R. M., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.006 · Cited by 226
Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?
Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2010) · Toxins · doi:10.3390/toxins2040517 · Cited by 225
Self-citationTargeting the tumor microenvironment
Kenny, P. (2007) · Frontiers in Bioscience · doi:10.2741/2327 · Cited by 220
A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers
Dudhatra, G. B., Mody, S. K., Awale, M. M., Patel, H. B., Modi, C. M., Kumar, A., Kamani, D. R., & Chauhan, B. N. (2012) · The Scientific World Journal · doi:10.1100/2012/637953 · Cited by 218
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213
DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells
Ohnishi, S., Ma, N., Thanan, R., Pinlaor, S., Hammam, O., Murata, M., & Kawanishi, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/387014 · Cited by 207
Kanai, M., Otsuka, Y., Otsuka, K., Sato, M., Nishimura, T., Mori, Y., Kawaguchi, M., Hatano, E., Kodama, Y., Matsumoto, S., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2151-8 · Cited by 198
The role of glutathione in brain tumor drug resistance
Backos, D. S., Franklin, C. C., & Reigan, P. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.016 · Cited by 196
Tabung, F. K., Steck, S. E., Ma, Y., Liese, A. D., Zhang, J., Caan, B., Hou, L., Johnson, K. C., Mossavar-Rahmani, Y., Shivappa, N., et al. (2015) · Cancer Causes & Control · doi:10.1007/s10552-014-0515-y · Cited by 193
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Verhoeff, J. J., van Tellingen, O., Claes, A., Stalpers, L. J., van Linde, M. E., Richel, D. J., Leenders, W. P., & van Furth, W. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-444 · Cited by 189
Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188
Friedenreich, C. M., Woolcott, C. G., McTiernan, A., Ballard-Barbash, R., Brant, R. F., Stanczyk, F. Z., Terry, T., Boyd, N. F., Yaffe, M. J., Irwin, M. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9557 · Cited by 184
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
Zhai, B. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i7.345 · Cited by 183
Drug resistance and the microenvironment: nature and nurture
Morin, P. J. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00059-1 · Cited by 182
Rees, L. (2001) · BMJ · doi:10.1136/bmj.322.7279.119 · Cited by 179
Kelley, D. S., Rasooly, R., Jacob, R. A., Kader, A. A., & Mackey, B. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.4.981 · Cited by 179
Quercetin: A Pleiotropic Kinase Inhibitor Against Cancer
Russo, G. L., Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Iannitti, R., & Palumbo, R. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_11 · Cited by 167
Self-citationKast, R. E., Boockvar, J. A., Brüning, A., Cappello, F., Chang, W.-W., Cvek, B., Dou, Q. P., Duenas-Gonzalez, A., Efferth, T., Focosi, D., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.969 · Cited by 167
Self-citationThe Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
Niraula, S., Seruga, B., Ocana, A., Shao, T., Goldstein, R., Tannock, I. F., & Amir, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.3824 · Cited by 167
Diet, Supplement Use, and Prostate Cancer Risk: Results From the Prostate Cancer Prevention Trial
Kristal, A. R., Arnold, K. B., Neuhouser, M. L., Goodman, P., Platz, E. A., Albanes, D., & Thompson, I. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq148 · Cited by 166
4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy
Vinay, D. S., & Kwon, B. S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.283 · Cited by 165
Self-citationPanis, C., Herrera, A. C. S. A., Victorino, V. J., Campos, F. C., Freitas, L. F., De Rossi, T., Colado Simão, A. N., Cecchini, A. L., & Cecchini, R. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1693-x · Cited by 164
Self-citationHypoxia and lymphangiogenesis in tumor microenvironment and metastasis
Ji, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.001 · Cited by 164
Hyperforin in St. John’s wort drug interactions
Madabushi, R., Frank, B., Drewelow, B., Derendorf, H., & Butterweck, V. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0096-0 · Cited by 162
How Drugs are Developed and Approved by the FDA: Current Process and Future Directions
Ciociola, A. A., Cohen, L. B., Kulkarni, P., Kefalas, C., Buchman, A., Burke, C., Cain, T., Connor, J., Ehrenpreis, E. D., Fang, J., et al. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.407 · Cited by 162
Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer Inhibition
Trejo‐Solís, C., Pedraza‐Chaverrí, J., Torres-Ramos, M., Jiménez‐Farfán, D., Cruz-Salgado, A., Serrano‐García, N., Osorio‐Rico, L., & Sotelo, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/705121 · Cited by 162
Wang, Y., Fan, X., Qu, H., Gao, X., & Cheng, Y. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612801319034 · Cited by 158
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 158
Self-citationDiet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis
Pendyala, S., Neff, L. M., Suárez‐Fariñas, M., & Holt, P. R. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002683 · Cited by 156
Triptolide in the treatment of psoriasis and other immune‐mediated inflammatory diseases
Han, R., Rostami‐Yazdi, M., Gerdes, S., & Mrowietz, U. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04221.x · Cited by 155
Ishikawa, H., Saeki, T., Otani, T., Suzuki, T., Shimozuma, K., Nishino, H., Fukuda, S., & Morimoto, K. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.816s · Cited by 151
Cao, Y. (2004) · The biomedical & life sciences collection. · doi:10.1016/j.semcancer.2003.09.018 · Cited by 148
Foodstuffs for Preventing Cancer: The Preclinical and Clinical Development of Berries
Stoner, G. D. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0226 · Cited by 147
Schwarze, S. R., Fu, V. X., Desotelle, J. A., Kenowski, M. L., & Jarrard, D. F. (2005) · Neoplasia · doi:10.1593/neo.05250 · Cited by 145
Anti-VEGF– and anti-VEGF receptor–induced vascular alteration in mouse healthy tissues
Yang, Y., Zhang, Y., Cao, Z., Ji, H. L., Yang, X., Iwamoto, H., Wahlberg, E., Länne, T., Sun, B., & Cao, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301331110 · Cited by 143
Self-citationPanis, C., Victorino, V. J., Herrera, A. C. S. A., Freitas, L. F., De Rossi, T., Campos, F. C., Simão, A. N. C., Barbosa, D. S., Pinge-Filho, P., Cecchini, R., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1851-1 · Cited by 138
Self-citationHopkins, M. H., Owen, J. R., Ahearn, T. U., Fedirko, V., Flanders, W. D., Jones, D. P., & Bostick, R. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0105 · Cited by 138
Future development of global regulations of Chinese herbal products
Fan, T.-P., Deal, G., Koo, H.-L., Rees, D., Sun, H., Chen, S., Dou, J.-H., Makarov, V. G., Pozharitskaya, O. N., Shikov, A. N., et al. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.02.029 · Cited by 137
Self-citationLutgendorf, S. K., Mullen-Houser, E., Russell, D. W., DeGeest, K., Jacobson, G., Hart, L. K., Bender, D., Anderson, B., Buekers, T., Goodheart, M. J., et al. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.014 · Cited by 136
Peeters, C. F. J. M., de Waal, R. M. W., Wobbes, T., Westphal, J. R., & Ruers, T. J. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21928 · Cited by 127
Weber, J. S., Hua, F. L., Spears, L., Marty, V., Kuniyoshi, C., & Celis, E. (1999) · Journal of Immunotherapy · doi:10.1097/00002371-199909000-00007 · Cited by 125
The role of epigenetic transcription repression and DNA methyltransferases in cancer
Daniel, F. I., Cherubini, K., Yurgel, L. S., de Figueiredo, M. A. Z., & Salum, F. G. (2010) · Cancer · doi:10.1002/cncr.25482 · Cited by 122
Effects of Exercise on Immune Function in Patients with Cancer: a Systematic Review
Kruijsen-Jaarsma, M., Buffart, L. M., Bierings, M., Buffart, L. M., & Takken, T. (2026) · PubMed · doi:10.22029/eir.2013.1682 · Cited by 120
Neuhouser, M. L., Schwarz, Y., Wang, C., Breymeyer, K. L., Coronado, G. D., Wang, C.-Y., Noar, K. A., Song, X., & Lampe, J. W. (2011) · Journal of Nutrition · doi:10.3945/jn.111.149807 · Cited by 117
Setchell, K. D. R., Brown, N. M., Zhao, X., Galandi, S. L., Heubi, J. E., King, E. C., & Messina, M. J. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.019638 · Cited by 115
Ranjan, A. P., Mukerjee, A., Helson, L., Gupta, R. V., & Vishwanatha, J. K. (2013) · PubMed · Cited by 111
Golombick, T., DIAMOND, T. H., Manoharan, A., & Ramakrishna, R. (2012) · American Journal of Hematology · doi:10.1002/ajh.23159 · Cited by 110
Chemopreventive and Therapeutic Potential of Tea Polyphenols in Hepatocellular Cancer
Darvesh, A. S., & Bishayee, A. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.767367 · Cited by 110
Self-citationZhu, H., Brinda, B. J., Chavin, K. D., Bernstein, H. J., Patrick, K. S., & Markowitz, J. S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052423 · Cited by 107
Discovery of anticancer agents of diverse natural origin
Kinghorn, A. D., de Blanco, E. J. C., Chai, H., Orjala, J., Farnsworth, N. R., Soejarto, D. D., Oberlies, N. H., Wani, M. C., Kroll, D. J., Pearce, C. J., et al. (2009) · Pure and Applied Chemistry · doi:10.1351/pac-con-08-10-16 · Cited by 104
Inflammation, Aging, and Cancer: Tumoricidal Versus Tumorigenesis of Immunity
Khatami, M. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9059-2 · Cited by 100
Self-citationAccelerated growth of testicular cancer after cytoreductive surgery
Lange, P. H., Hekmat, K., Bosl, G. J., Kennedy, B. J., & Fraley, E. E. (1980) · Cancer · doi:10.1002/1097-0142(19800315)45:6<1498::aid-cncr2820450633>3.0.co;2-7 · Cited by 99
Herbal Composition PC-SPES for Management of Prostate Cancer: Identification of Active Principles
Sovák, M. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.17.1275 · Cited by 98
Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
Ramakrishnan, R., & Gabrilovich, D. I. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1390-6 · Cited by 97
Jochéms, C., Tucker, J. A., Tsang, K.-Y., Madan, R. A., Dahut, W. L., Liewehr, D. J., Steinberg, S. M., Gulley, J. L., & Schlom, J. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1524-0 · Cited by 97
Perez, A., Arun, B. K., Tripathy, D., Tagliaferri, M. A., Shaw, H. S., Kimmick, G. G., Cohen, I. V., Shtivelman, E., Caygill, K. A., Grady, D. G., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0678-5 · Cited by 94
Cancer-linked targets modulated by curcumin.
Hasima, N., & Aggarwal, B. B. (2012) · PubMed · Cited by 92
Pereira, A. G. B., Fajardo, A. R., Nocchi, S. R., Nakamura, C. V., Rubira, A. F., & Muniz, E. C. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.06.013 · Cited by 90
Ge, J., Tan, B., Chen, Y., Yang, L., Peng, X., Li, H.-Z., Lin, H., Zhao, Y. W., Wei, M., Cheng, K., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0737-3 · Cited by 89
Self-citationThe Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
Ribas, A., & Tumeh, P. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0933 · Cited by 89
Kefford, R. F., Ribas, A., Hamid, O., Robert, C., DAUD, A. I., Wolchok, J. D., Joshua, A. M., Hodi, F. S., Gangadhar, T. C., Hersey, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.3005 · Cited by 89
Crawford, S. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014521111 · Cited by 87
Self-citationWu, P., Dugoua, J.-J., Eyawo, O., & Mills, E. J. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-112 · Cited by 77
de Miranda Torrinhas, R. S. M., Santana, R., Garcia, T., Cury-Boaventura, M. F., Sales, M. M., Curi, R., & Waitzberg, D. L. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.12.008 · Cited by 76
Ensuring the safety of botanical dietary supplements
van Breemen, R. B., Fong, H. H. S., & Farnsworth, N. R. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.509s · Cited by 75
Krishnan, A. V., Moreno, J., Nonn, L., Swami, S., Peehl, D. M., & Feldman, D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.07s213 · Cited by 74
Saif, M. W., Li, J., Lamb, L. A., Kaley, K., Elligers, K., Jiang, Z., Bussom, S., Liu, S.-H., & Cheng, Y. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2359-7 · Cited by 72
Eremin, O., Walker, M. B., Simpson, E., Heys, S. D., Ah-See, A. K., Hutcheon, A. W., Ogston, K. N., Sarkar, T. K., Segar, A., & Walker, L. G. (2008) · The Breast · doi:10.1016/j.breast.2008.09.002 · Cited by 71
Antithrombotic Effects of Naturally Derived Products on Coagulation and Platelet Function
Mousa, S. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-803-4_9 · Cited by 70
Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics.
Mencalha, A. L., Victorino, V. J., Cecchini, R., & Panis, C. (2014) · PubMed · Cited by 69
Self-citationPan, M., Chiou, Y.-S., Wang, Y.-J., Ho, C., & Lin, J.-K. (2011) · Food & Function · doi:10.1039/c0fo00174k · Cited by 69
Resveratrol in the management of human cancer: how strong is the clinical evidence?
Gescher, A. J., Steward, W. P., & Brown, K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12205 · Cited by 67
Effects of herbal products on the metabolism and transport of anticancer agents
He, S.-M., Yang, A.-K., Li, X., Du, Y.-M., & Zhou, S.-F. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.510132 · Cited by 67
Feitelson, M. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.009 · Cited by 66
Self-citationVitamin B6 and colorectal cancer: Current evidence and future directions
Zhang, X. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i7.1005 · Cited by 66
The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols
Thakur, V. S., Gupta, K., & Gupta, S. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868584 · Cited by 65
Merger of Ayurveda and Tissue Culture-Based Functional Genomics: Inspirations from Systems Biology
Deocaris, C. C., Widodo, N., Wadhwa, R., & Kaul, S. C. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-14 · Cited by 64
Understanding FOXO, New Views on Old Transcription Factors
Zanella, F., Link, W., & Carnero, A. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791054158 · Cited by 63
Self-citationFerguson, L. R., & Schlothauer, R. C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100507 · Cited by 62
Self-citationGreen tea catechins for treatment of external genital warts
Meltzer, S. M., Monk, B. J., & Tewari, K. S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.064 · Cited by 61
Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice
Du, M., Yang, X., Hartman, J. A., Cooke, P. S., Doerge, D. R., Ju, Y. H., & Helferich, W. G. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs017 · Cited by 61
Self-citationSporn, M. B. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48599.x · Cited by 61
Rusin, M., Zajkowicz, A., & Butkiewicz, D. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.06.005 · Cited by 60
Integrative Oncology: Best of Both Worlds—Theoretical, Practical, and Research Issues
Cramer, H., Cohen, L. G., Dobos, G., & Witt, C. M. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/383142 · Cited by 60
Role of Epigenetic Modifications in Luminal Breast Cancer
Abdel-Hafiz, H. A., & Horwitz, K. B. (2015) · Epigenomics · doi:10.2217/epi.15.10 · Cited by 59
Heymach, J. V., Shackleford, T. J., Tran, H. T., Yoo, S., Do, K.-A., Wergin, M., Saintigny, P., Vollmer, R. T., Polascik, T. J., Snyder, D. C., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0136 · Cited by 58
Systemic DNA damage responses: organismal adaptations to genome instability
Ermolaeva, M., & Schumacher, B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2013.12.001 · Cited by 51
Davis, N. J., Crandall, J. P., Gajavelli, S., Berman, J. W., Tomuta, N., Wylie‐Rosett, J., & Katz, S. D. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.08.001 · Cited by 50
Lu, Y., Sun, J., Petrova, K., Yang, X., Greenhaw, J. J., Salminen, W. F., Beger, R. D., & Schnackenberg, L. K. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.09.025 · Cited by 49
Self-citationColorectal Resection is Associated With Persistent Proangiogenic Plasma Protein Changes
Kumara, H. M. C. S., Feingold, D. L., Kalady, M. F., Dujovny, N., Senagore, A. J., Hyman, N., Cekic, V., & Whelan, R. L. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a6cd72 · Cited by 48
Self-citationAn updated review on asbestos and related diseases in China
Courtice, M. N., Lin, S., & Wang, X. (2012) · International Journal of Occupational and Environmental Health · doi:10.1179/1077352512z.00000000021 · Cited by 46
Jiang, J., Eliaz, I., & Slíva, D. (2012) · Integrative Cancer Therapies · doi:10.1177/1534735412442369 · Cited by 46
Capodice, J. L., Gorroochurn, P., Cammack, A. S., Eric, G., McKiernan, J. M., Benson, M. C., Stone, B. A., & Katz, A. E. (2009) · PubMed · Cited by 42
Sharp, L., Carsin, A., Cantwell Marie, M., Anderson, L. A., & Murray Liam, J. (2013) · Journal of Nutrition · doi:10.3945/jn.113.174664 · Cited by 42
Ullah, M. F., Ahmad, A., Khan, H. Y., Zubair, H., Sarkar, F. H., & Hadi, S. M. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9303-4 · Cited by 42
Inflammatory Response to a High‐fat, Low‐carbohydrate Weight Loss Diet: Effect of Antioxidants
Peairs, A., & Rankin, J. W. (2008) · Obesity · doi:10.1038/oby.2008.252 · Cited by 41
UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin
Chen, Y., Kuehl, G. E., Bigler, J., Rimorin, C. F., Schwarz, Y., Shen, D. D., & Lampe, J. W. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236339.79916.07 · Cited by 40
Self-citationDrug Repositioning: Playing Dirty to Kill Pain
Bastos, L. F. S., & Coelho, M. M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0128-0 · Cited by 37
Hollebecque, A., Massard, C., de Baère, T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2512 · Cited by 36
Xu, J., Mao, Q., Shen, H., Zhu, L., Li, S., & Yan, R. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.07.023 · Cited by 35
Mannello, F., Tonti, G. A., Pagliarani, S., Benedetti, S., Canestrari, F., Zhu, W., Qin, W., & Sauter, E. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22522 · Cited by 35
RB's original CIN?: Figure 1.Preprint
Sage, J., & Straight, A. F. (2010) · Genes & Development · doi:10.1101/gad.1948010 · Cited by 35
Stem-cell driven cancer: "Hands-off" regulation of cancer development
Vicente‐Dueñas, C., Pérez-Caro, M., Abollo‐Jiménez, F., Cobaleda, C., & Sánchez-Garcı́a, I. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8217 · Cited by 34
Lee, S. C., Chan, J. Y., & Pervaiz, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.020 · Cited by 33
A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges
Weiss, G. J., Liang, W. S., Demeure, M. J., Kiefer, J., Hostetter, G. H., Izatt, T., Sinari, S. A., Christoforides, A., Aldrich, J., Kurdoglu, A. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076438 · Cited by 32
Quality and Risk of Bias inPanax ginsengRandomized Controlled Trials: A Review
Shergis, J. L., Zhang, A. L., Zhou, W., & Xue, C. C. (2013) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x13500171 · Cited by 32
Daviglus, M. L., Liu, K., Pirzada, A., Yan, L. L., Garside, D. B., Wang, R., Horn, L. V., Manning, W. G., Manheim, L. M., Dyer, A. R., et al. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.08.008 · Cited by 32
Aravindan, S., Natarajan, M., Herman, T. S., Awasthi, V., & Aravindan, N. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-46 · Cited by 30
Huq, F., Yu, J., Beale, P. J., Chan, C., Arzuman, L., Nessa, M. U., & Mazumder, M. E. H. (2014) · PubMed · Cited by 29
Eduardo Fuentes, Q., & Palomo, I. F. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/861786 · Cited by 28
PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY
Kruse, V., Rottey, S., Backer, O. D., Belle, S. V., Cocquyt, V. F. J., & Denys, H. G. (2011) · Acta Clinica Belgica · doi:10.1179/acb.66.1.2062507 · Cited by 28
Epigenetic regulation leading to induced pluripotency drives cancer development in vivo
Ohnishi, K., Semi, K., & Yamada, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.020 · Cited by 27
Oncogene withdrawal engages the immune system to induce sustained cancer regression
Casey, S. C., Li, Y., Fan, A. C., & Felsher, D. W. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-24 · Cited by 27
Self-citationCombination of immunotherapy with anaerobic bacteria for immunogene therapy of solid tumours
Xu, J., Liu, X. S., Zhou, S., & Wei, M. Q. (2009) · Griffith Research Online · Cited by 26
Cited by
Elshafie, H. S., Camele, I., & Mohamed, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043266 · Cited by 439
The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells
Hazafa, A., Rehman, K.-U., Jahan, N., & Jabeen, Z. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2019.1637006 · Cited by 388
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364
Self-citationPlant flavonoids in cancer chemoprevention: role in genome stability
George, V. C., Dellaire, G., & Rupasinghe, H. P. V. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.11.007 · Cited by 362
Self-citationMigrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
Gandalovičová, A., Rosel, D., Fernandes, M., Veselý, P., Heneberg, P., Čermák, V., Petruželka, L., Kumar, S., Sanz-Moreno, V., & Brábek, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.008 · Cited by 351
Self-citation
Metadata
- Authors
- Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R. M. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., Ashraf, S. S., Azmi, A. S., Benencia, F., Bhakta, D., Bilsland, A., Bishayee, A., Blain, S. W., Block, P. B., Boosani, C. S., Carey, T. E., Carnero, A., Carotenuto, M., Casey, S. C., Chakrabarti, M., Chaturvedi, R., Chen, G. Z., Chen, H., Chen, S., Chen, Y. C., Choi, B. K., Ciriolo, M. R., Coley, H. M., Collins, A. R., Connell, M., Crawford, S., Curran, C. S., Dabrosin, C., Damia, G., Dasgupta, S., DeBerardinis, R. J., Decker, W. K., Dhawan, P., Diehl, A. M. E., Dong, J.-T., Dou, Q. P., Drew, J. E., Elkord, E., El-Rayes, B., Feitelson, M. A., Felsher, D. W., Ferguson, L. R., Fimognari, C., Firestone, G. L., Frezza, C., Fujii, H., Fuster, M. M., Generali, D., Georgakilas, A. G., Gieseler, F., Gilbertson, M., Green, M. F., Grue, B., Guha, G., Halicka, D., Helferich, W. G., Heneberg, P., Hentosh, P., Hirschey, M. D., Hofseth, L. J., Holcombe, R. F., Honoki, K., Hsu, H.-Y., Huang, G. S., Jensen, L. D., Jiang, W. G., Jones, L. W., Karpowicz, P. A., Keith, W. N., Kerkar, S. P., Khan, G. N., Khatami, M., Ko, Y. H., Kucuk, O., Kulathinal, R. J., Kumar, N. B., Kwon, B. S., Le, A., Lea, M. A., Lee, H.-Y., Lichtor, T., Lin, L.-T., Locasale, J. W., Lokeshwar, B. L., Longo, V. D., Lyssiotis, C. A., MacKenzie, K. L., Malhotra, M., Marino, M., Martinez-Chantar, M. L., Matheu, A., Maxwell, C., McDonnell, E., Meeker, A. K., Mehrmohamadi, M., Mehta, K., Michelotti, G. A., Mohammad, R. M., Mohammed, S. I., Morre, D. J., Muralidhar, V., Muqbil, I., Murphy, M. P., Nagaraju, G. P., Nahta, R., Niccolai, E., Nowsheen, S., Panis, C., Pantano, F., Parslow, V. R., Pawelec, G., Pedersen, P. L., Poore, B., Poudyal, D., Prakash, S., Prince, M., Raffaghello, L., Rathmell, J. C., Rathmell, W. K., Ray, S. K., Reichrath, J., Rezazadeh, S., Ribatti, D., Ricciardiello, L., Robey, R. B., Rodier, F., Rupasinghe, H. P. V., Russo, G. L., Ryan, E. P., Samadi, A. K., Sanchez-Garcia, I., Sanders, A. J., Santini, D., Sarkar, M., Sasada, T., Saxena, N. K., Shackelford, R. E., Shantha Kumara, H. M. C., Sharma, D., Shin, D. M., Sidransky, D., Siegelin, M. D., Signori, E., Singh, N., Sivanand, S., Sliva, D., Smythe, C., Spagnuolo, C., Stafforini, D. M., Stagg, J., Subbarayan, P. R., Sundin, T., Talib, W. H., Thompson, S. K., Tran, P. T., Ungefroren, H., Vander Heiden, M. G., Venkateswaran, V., Vinay, D. S., Vlachostergios, P. J., Wang, Z., Wellen, K. E., Whelan, R. L., Yang, E. S., Yang, H., Yang, X., Yaswen, P., Yedjou, C., Yin, X., Zhu, J., & Zollo, M.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S276-S304
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2177390620
- Cited by
- 300
- References
- 214
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.